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550Ventricular ﬁbrillation (VF) is a
frequent and potentially lethal
complication of acute myocardial
infarction (MI). In this setting,
VF is the consequence of dis-
turbed electrical properties of
the ischemic myocardium, which
includes a decrease in cardio-
myocyte excitability and cell-
to-cell coupling. These factors
result in conduction slowing of the
cardiac electrical impulse, which is
a prerequisite for the occurrence of
life-threatening arrhythmias such
as VF in MI (1).See page 560Traditional cardiovascular risk
factors do not identify which
patient with MI is at risk for VF,
and speciﬁc and sensitive riskpredictors are currently lacking. A heritable component in
the determination of risk of VF and sudden cardiac death
during MI has been well established (2,3), but progress in
understanding the molecular and genetic determinants
of ischemia-induced VF has been limited. To identify
susceptibility genes, our group recently conducted a genome-
wide association study (GWAS) that led to the identiﬁcation
of common genetic variants at the chromosome 21q21 locus
associated with the risk of VF in the setting of acute MI (4).
The most signiﬁcant association signal for VF on the chro-
mosome 21q21 locus comprised the single nucleotide poly-
morphism rs2824292, located immediately upstream of 2
genes, CXADR and BTG3 (the only genes within a region of
1 megabase spanning the association signal) (4). The BTG3
gene encodes B-cell translocation gene 3, a member of the
antiproliferative BTG/Tob protein family, known to regulate
cell cycle progression, gene expression, tumorigenesis, and
cancer (5). The CXADR gene encodes the coxsackie and
adenovirus receptor (CAR), a transmembrane cell adhesion
molecule predominantly located at the intercalated disk
between cardiomyocytes (6–9). CAR has been recognized
primarily for its involvement in virus-mediated myocarditis,Berlin, Germany. This study was supported by
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revised manuscript received October 13, 2013,but recent studies in CAR knockout mice revealed
atrioventricular conduction slowing due to loss of expression
of the gap junction protein connexin (Cx) 45 (9,10).
Moreover, expression levels of Cx43, the predominant gap
junction molecule in ventricular myocardium, were
decreased in hearts from CAR knockout mice (9), raising
the possibility that CAR may play a role in ventricular
conduction. Of note, CAR is known to be differentially
regulated in various cardiac disease states, including dilated
cardiomyopathy and MI (6,11).
We hypothesized that CAR affects ventricular conduction
and susceptibility to ventricular arrhythmia in the setting of
MI and show that the rs2824292 risk genotype is associated
with decreased expression of CXADR in the human heart.
Furthermore, we show that mice haploinsufﬁcient for CAR
display ventricular conduction slowing and an earlier onset
of ventricular arrhythmias during MI, at least in part
mediated by a reduced sodium current (INa) magnitude at
the intercalated disk.Methods
The methods are provided in the Online Appendix.Results
rs2824292 regulates cardiac expression of CXADR, the
gene encoding CAR. Because the risk haplotype tagged by
rs2824292 occurs in a noncoding region of chr21q21,
it is likely to affect the risk of VF through effects on
gene expression. We therefore investigated whether the
rs2824292 genotype correlates to transcript expression
levels of the only 2 neighboring genes within 1 megabase,
namely CXADR (located 100 kilobases downstream of
rs2824292) and BTG3 (located 179 kilobases downstream).
Assessment of transcript abundance for these genes in
normal donor heart myocardium (n ¼ 129) uncovered an
association between the genotype at rs2824292 and cardiac
CXADR messenger ribonucleic acid (mRNA) levels
(Fig. 1). Subjects carrying 1 or 2 copies of the risk allele
(AG or GG genotype) displayed signiﬁcantly lower (0.6-
fold) CXADR mRNA expression compared with subjects
with the nonrisk (AA) genotype (dominant model: p ¼
0.002; additive model: p ¼ 0.006). No such relationship
was observed with cardiac expression of BTG3. Thus, the
VF risk allele at rs2824292 is associated with decreased
cardiac expression of CXADR, suggesting that decreased
levels of CAR predispose to VF during ischemia.
CAR haploinsufﬁcient mice. To investigate the effects of
reduced CAR expression on cardiac conduction and
arrhythmogenesis, we generated mice deﬁcient for CAR
(Online Fig. 1) (12). Homozygous CAR-deﬁcient mice were
not viable and died midgestation between embryonic days
10.5 and 12.5 (Online Fig. 2, Online Table 1). Heterozygous
CAR-deﬁcient mice (CARþ/) were born at the expected
Mendelian ratio (Online Table 1) and had a normal life span.
Figure 1 rs2824292 Regulates Cardiac CXADR Levels
(A) The human 21q21 locus. CXADR and BTG3 are located within a 500-kilobase region downstream of rs2824292. (B) Mean mRNA expression of CXADR and BTG3 as a
function of genotype at rs2824292 in human heart samples, standardized to the geomean of cTNI and HPRT mRNA expression levels (*p ¼ 0.05; **p < 0.01). Mean
expression levels in hearts from AG heterozygotes and GG homozygotes are normalized to the mean expression levels from hearts of AA homozygotes. bp ¼ base pairs;
mRNA ¼ messenger ribonucleic acid.
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551Earlier onset of inducible ventricular arrhythmias during
acute myocardial ischemia in CARD/Lmouse hearts. To
investigate whether reduced CAR levels predispose to
arrhythmia during acute myocardial ischemia, we induced
regional ischemia in Langendorff-perfused wild-type (WT)
and CARþ/ hearts by ligating the left anterior descending
(LAD) artery and tested arrhythmia inducibility. Ischemic
zone size was not signiﬁcantly different between WT and
CARþ/ hearts (Fig. 2A). Hearts were stimulated from the
nonischemic area at a basic cycle length of 120 ms (S1), and
arrhythmia inducibility was tested before ligation of the
LAD artery and at different intervals during ischemia using
up to 3 extrastimuli (S2-S3-S4) and burst pacing. Sponta-
neous sustained arrhythmias did not occur inWT or CARþ/
hearts at baseline or during the ischemic period. Arrhyth-
mias were never induced before ligation of the LAD artery
but were induced in all WT and CARþ/ hearts during
ischemia. These included premature ventricular contrac-
tions, nonsustained ventricular tachycardia (VT), and sus-
tained VT (Fig. 2B). During the ﬁrst 15 min of ischemia, we
observed inducible arrhythmias (nonsustained and sus-
tained) in 7 of 9 CARþ/ hearts. In contrast, arrhythmias
were induced in only 1 of 8 WT hearts (p < 0.05) (Figs. 2C
and 2D). Similarly, in the ﬁrst 15 min of ischemia, there
was a trend toward a higher prevalence of inducible sus-
tained VT (>3 s) in CARþ/ compared with WT hearts
(Fig. 2E). During later stages of the ischemic episode,
arrhythmia inducibility was not different between WTand CARþ/ hearts. Thus, CARþ/ hearts displayed an
advanced onset of ventricular arrhythmia inducibility during
the early phase of acute myocardial ischemia.
Ventricular conduction slowing in isolated CARD/L
hearts. We hypothesized that altered electrophysiological
properties secondary to CAR deﬁciency render CARþ/
hearts more susceptible to arrhythmia inducibility in the
setting of myocardial ischemia. Surface electrocardiographic
analysis showed no signiﬁcant differences in electrocardio-
graphic parameters (RR, PQ, QRS, and QTc intervals)
between CARþ/ and WT mice (Online Fig. 3). We
therefore studied ventricular conduction in more detail by
electrical mapping of isolated WT and CARþ/ hearts. A
247-point electrode was placed on the left ventricular
epicardial surface, and hearts were stimulated from the
center of the electrode. Local electrograms were used to
construct activation maps (Fig. 3A), from which longitudi-
nal conduction velocity (CVL) and transversal conduction
velocity (CVT) were determined. The stimulation threshold
and shortest coupled intervals of S2, S3, and S4 (effective
refractory period) were not signiﬁcantly different between
CARþ/ and WT hearts (Online Table 3). During basic
stimulation (S1), CVL (CARþ/: 63.7  4.7 cm/s; WT:
77.8  2.8 cm/s; p ¼ 0.02) and CVT (CARþ/: 28.6  2.0
cm/s; WT: 38.0  2.5 cm/s; p ¼ 0.01) were signiﬁcantly
reduced in CARþ/ compared with WT hearts (Figs. 3B
and 3C). These differences in conduction velocity were also
observed after application of 3 extrastimuli (S4; CARþ/:
Figure 2 Accelerated Onset of Inducible Arrhythmias During Myocardial Ischemia in Isolated CARþ/ Hearts
(A) Ischemic zone size after ligation of the LAD artery (nonperfused area; as a percentage of the left ventricle) was similar in WT and CARþ/ hearts. (B) Arrhythmia inducibility
during ligation of the LAD artery. Typical examples of ventricular electrograms show extrastimuli (S1 to S4) followed by either arrhythmia (upper panel), 6 ventricular extra-
systoles (PVCs) (middle panel), or sustained VT (lower panel). (C) Kaplan-Meier plot showing an accelerated onset of ﬁrst arrhythmic event during myocardial ischemia in
CARþ/ hearts (n ¼ 9) as compared with WT (n ¼ 8). (D and E) CARþ/ hearts display increased inducibility of (D) all types of arrhythmia and (E) sustained VT (>3 s) during
the ﬁrst 15 min of ischemia (*p < 0.05). CAR ¼ coxsackie and adenovirus receptor; LAD ¼ left anterior descending; LV ¼ left ventricular; PVC ¼ premature ventricular
contraction; VT ¼ ventricular tachycardia; WT ¼ wild-type.
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55242.5  4.6 cm/s; WT: 55.5  4.2 cm/s; p ¼ 0.054) and
CVT (CARþ/: 28.6  1.8 cm/s; WT: 33.9  1.5 cm/s;
p ¼ 0.04) (Figs. 3B and 3C).
Pharmacological electrical uncoupling induces ventricular
arrhythmias in CARD/L hearts. Conduction slowing in
CARþ/ hearts may stem from altered tissue architecture,
cell-to-cell coupling, and/or cardiomyocyte excitability. No
evidence for myocardial hypertrophy or ﬁbrosis was found in
CARþ/ hearts (Online Fig. 4). In addition, transmission
electron microscopy did not reveal ultrastructural changes
in CARþ/ hearts (Online Fig. 5). To evaluate whether
the conduction slowing in CARþ/ hearts is mediated by
alterations in gap junction composition and/or function, we
investigated the expression and distribution of connexins
and challenged WT and CARþ/ hearts with the gap
junction uncoupler carbenoxolone. Carbenoxolone is known
to decrease conduction velocity both in the longitudinal and
transversal direction without affecting action potential (AP)
characteristics and underlying ionic currents (13). During
stimulation at basic cycle length (S1), carbenoxolonesigniﬁcantly reduced CVL in both WT and CARþ/ hearts
(Fig. 3B). Similarly, CVT was decreased by carbenoxolone
in WT and CARþ/ hearts after application of 3 extra-
stimuli (S4) (Fig. 3C).
The consequences of the observed conduction slowing
after infusion of carbenoxolone with respect to arrhyth-
mia inducibility were tested using up to 3 extrastimuli
(S2-S3-S4) and burst pacing. The shortest possible coupling
intervals of S2-S3-S4 and burst trains were not signiﬁcan-
tly different between CARþ/ and WT hearts at baseline
and after infusion of carbenoxolone (Online Table 3).
Spontaneous arrhythmias did not occur in either experi-
mental group, and we were unable to induce arrhythmias in
WT or CARþ/ hearts at baseline. Although none of the
WT hearts showed induced arrhythmias on infusion of
carbenoxolone, 50% of the CARþ/ hearts developed sus-
tained ventricular arrhythmias during burst pacing after
administration of carbenoxolone (CARþ/: 4/8; WT: 0/9;
p ¼ 0.015) (Figs. 4A and 4B). VTs induced in CARþ/
hearts after infusion of carbenoxolone were reproducible
Figure 3 Ventricular Conduction Slowing in CARþ/ Hearts
(A) Representative left ventricular epicardial activation maps at baseline and after infusion of CBX in WT and CARþ/ hearts. Crowding of isochrones is indicative of conduction
slowing. Average (B) longitudinal and (C) transversal conduction velocities measured during basic stimulation (120 ms) and 3 extrastimuli (S4) at baseline and after
administration of CBX (*p < 0.05 CARþ/ vs. WT; #p < 0.05 CBX vs. baseline). BCL ¼ basic cycle length (120 ms); CBX ¼ carbenoxolone; other abbreviations as in Figure 2.
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553and lasted for more than 5 s to 1 min. Activation maps of
2 consecutive beats of an induced ventricular tachycardia in
a CARþ/ heart show the impulse propagating around a
line of block, indicating a re-entrant mechanism underlying
the arrhythmia (Fig. 4C). Ventricular mRNA and protein
levels of the gap junction proteins Cx43 and Cx45 were
not different between WT and CARþ/ hearts (Figs. 5A to
5C), and there were no differences in distribution of Cx43
(in particular, no lateralization or redistribution) in ventric-
ular cryosections (Fig. 5D) and isolated myocytes (Online
Fig. 6). Protein expression levels of other intercalated disk
proteins, namely b-catenin, zonula occludens 1, N-cadherin,
and Cx45, were not different between WT and CARþ/
hearts (Online Fig. 7, Online Table 2).
Reduced sodium channel availability in CARD/L mice
and cardiomyocytes. Because the cardiac sodium channel
protein NaV1.5 is enriched in the intercalated disk region,
CAR may also have an impact on conduction by affectingsodium channel expression and/or function. Scn5a mRNA
and NaV1.5 protein levels were not different between
CARþ/ and WT ventricular tissue (Figs. 5A to 5C), and
there were no differences in NaV1.5 localization at the
intercalated disk or lateral membrane (Fig. 5D). Function-
ally, however, AP upstroke velocity (dV/dtmax, a measure of
sodium channel availability under near-physiological con-
ditions [14]) was altered in cardiomyocytes isolated from
CARþ/ hearts (Figs. 6A and 6B). On average, dV/dtmax
was z15% lower in CARþ/ myocytes as compared with
WT, indicating a decrease in functional sodium channel
availability secondary to CAR haploinsufﬁciency. Resting
membrane potential, AP amplitude, and AP duration were
unchanged in CARþ/ cardiomyocytes (Fig. 6B). In vivo
short-term administration of the sodium channel blocker
ﬂecainide in anesthetized mice revealed a signiﬁcantly larger
increase in PR interval and QRS duration in CARþ/ versus
WT mice, underlining the functional relevance of the
Figure 4 Increased Arrhythmia Inducibility After Infusion of CBX in CARþ/ Hearts
(A) Example of a sustained ventricular arrhythmia induced by burst pacing in a CARþ/ heart after infusion of CBX. (B) Increased incidence of inducible arrhythmias after infusion
of CBX in CARþ/ hearts as compared with WT (p ¼ 0.015). (C) Activation maps of 2 consecutive VT beats induced in a CARþ/ heart showing the impulse propagating around a
line of functional conduction block, indicating a re-entrant mechanism. The right panel depicts electrograms at positions A, B, C, and A0 that correspond to recording sites as
indicated in the activation maps (left panel). Local activation times are determined as the maximal negative dV/dt in each electrogram (indicated by red dots). Abbreviations as
in Figures 2 and 3.
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554reduced sodium channel availability for cardiac conduction
(Online Figs. 3C and 3D).
CAR haploinsufﬁciency affects INa magnitude speciﬁcally
at the intercalated disk. Sodium channels are located both
at the lateral membrane and at the intercalated disk of the
cardiomyocyte (15,16). Because CAR is localized pre-
dominantly at the intercalated disk, we hypothesized that
CAR deﬁciency affects INa preferentially in this region.
We therefore investigated INa characteristics at the lateral
membrane and at the intercalated disk of isolated CARþ/
and WT ventricular myocytes using the macropatch
cell-attached mode of the patch-clamp technique, which
allows for regional assessment of INa amplitude and gating
properties at a physiological temperature (36C) (17). At
the lateral membrane, the number of functional sodium
channels (INa amplitude) was similar in WT and CAR
þ/
cardiomyocytes (Fig. 6C). However, a signiﬁcant decrease
in INa amplitude at the intercalated disk was observed in
CARþ/ cardiomyocytes as compared with WT (Fig. 6D).Voltage dependence of INa activation and inactivation was
not signiﬁcantly different between WT and CARþ/ at
the lateral membrane or at the intercalated disk (Figs. 6E
and 6F). These ﬁndings indicate that CAR haplo-
insufﬁciency leads to reduced sodium channel availability
secondary to a decreased INa amplitude at the intercalated
disk.
Physical interaction between NaV1.5 and CAR. To
determine if CAR affects NaV1.5 function through a
physical association, we performed coimmunoprecipitation
studies. FLAG-tagged human NaV1.5 and/or human CAR
was transiently overexpressed in HEK293 cells, and cell
lysates were incubated with anti-FLAG afﬁnity beads.
Overexpressed CAR was not found to precipitate with anti-
FLAG beads in the absence of NaV1.5 (Fig. 7). In contrast,
immunoblotting of eluates from HEK293 cells over-
expressing both NaV1.5 and CAR revealed that CAR
coprecipitates with NaV1.5 (Fig. 7), indicating a direct or
indirect physical interaction between the 2 proteins.
Figure 5 Unaltered Cx43 and NaV1.5 Expression and Distribution in CAR
þ/ Hearts
(A) LV Cx43, Scn5a, and Car mRNA levels (n ¼ 4 per group, *p < 0.05). (B) Immunoblots of NaV1.5, Cx43, and CAR (whole cell and membrane fraction; calnexin as a loading
control). (C) NaV1.5, Cx43, and CAR protein levels (normalized to WT littermate control; n ¼ 5 mice in each group; *p < 0.05). (D) Immunoﬂuorescent stainings of Cx43 and
NaV1.5 in LV tissue; pan-cadherin (Pan-cadh) and N-cadherin (N-cadh) were used as intercalated disk markers. Cx ¼ connexin; other abbreviations as in Figures 1 and 2.
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555Discussion
Our current work follows up on the discovery by a GWAS
of a genetic locus on chromosome 21q21 associated with
vulnerability for VF in the setting of acute MI (4). We show
that in human cardiac tissue, the risk allele at this locus is
associated with decreased cardiac expression of CXADR,
suggesting that reduced levels of CAR predispose to VF
during ischemia. Reduced expression of CAR in CAR
haploinsufﬁcient mice leads to slowing of ventricular con-
duction and earlier onset of inducible ventricular arrhyth-
mias during acute regional myocardial ischemia, mediated
(at least in part) through a reduction of INa magnitude
speciﬁcally at the intercalated disk. Our ﬁndings thus
establish CAR as a novel modiﬁer of cardiac conduction
and arrhythmia vulnerability in myocardial ischemia and
indicate the usefulness of GWAS for the identiﬁcation
of novel determinants of complex phenotypes such as
arrhythmia.The rs2824292 single nucleotide polymorphism at the
arrhythmia susceptibility locus on 21q21 is associated
with reduced cardiac CXADR expression. In a recent
GWAS, we identiﬁed a susceptibility locus for VF during
a ﬁrst acute MI at chromosome 21q21 (4). The risk
haplotype at this locus, tagged by rs2824292, occurred at
an intergenic region and thus likely modulates the risk of
VF through effects on gene expression (18). Of the 2 genes
at this locus (CXADR and BTG3), CXADR appears to be
the most biologically plausible because previous studies
have shown its myocardial localization at the intercalated
disk and its modulatory effect on connexin expression and
atrioventricular conduction (9,10). Our ﬁnding that carri-
ership of the risk (G) allele at rs2824292 is associated with
reduced expression of the CXADR gene encoding CAR in
human heart samples supports the proposition that the
effect of the 21q21 locus on ischemia-induced arrhythmia
is mediated by CAR and suggests that decreased cardiac
Figure 6 Reduced Sodium Channel Availability and Decreased INa Amplitude at the Intercalated Disk in CAR
þ/ Cardiomyocytes
(A) APs measured from isolated LV cardiomyocytes of WT and CARþ/ hearts (inset: dV/dt of the AP upstroke). (B) Average AP characteristics. Maximal AP upstroke velocity
(dV/dtmax) was signiﬁcantly lower in CARþ/ myocytes as compared with WT (*p < 0.05). Resting membrane potential, APA, and APD at 20%, 50%, and 90% of repolarization
(APD20, APD50, and APD90, respectively) were not different between WT and CAR
þ/ myocytes. (C and D) Current-voltage (I-V) relationships show similar INa amplitude at the
lateral membrane of WT and CARþ/ cardiomyocytes (C) but reduced INa amplitude in CAR
þ/ versus WT at the intercalated disk (assessed by 2-way repeated-measures
analysis of variance followed by Holm-Sidak post-hoc testing; p ¼ 0.002 for overall effect) (D). Asterisks denote membrane potentials at which INa amplitude is signiﬁcantly
different between WT and CARþ/. (E and F) Average voltage dependencies of activation and inactivation show no signiﬁcant difference between WT and CARþ/ at the lateral
membrane (E) or at the intercalated disk (ID) (F). AP ¼ action potential; APA ¼ action potential amplitude; APD ¼ action potential duration; INa ¼ sodium current; RMP ¼ resting
membrane potential; other abbreviations as in Figure 2.
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556levels of CAR predispose to VF. The GWAS for
ischemia-induced VF, which identiﬁed the chr21q21 risk
locus, is thus far the only study of this speciﬁc clinical
presentation. Genetic studies of this phenotype are hin-
dered by the unavailability of large patient sets; indeed, a
study by Bugert et al. (19) in a small case-control set didnot detect the association of rs2824292 with VF. Thus,
although the effect of the variant/haplotype that we
detected on CXADR expression is in line with our previous
GWAS ﬁndings, the robustness of this signal must be
further validated in future association studies in larger
patient sets.
Figure 7 CAR Interacts With NaV1.5 In Vitro
The left panel (“input”) shows input levels of NaV1.5 and CAR in lysates of
HEK293A cells overexpressing FLAG-tagged NaV1.5 (lane 1), CAR (lane 2), or FLAG-
tagged NaV1.5 together with CAR (lane 3) versus untransfected cells (lane 4). The
right panel (“eluate”) shows levels of NaV1.5 and CAR after elution from FLAG-
agarose beads. Neither overexpressed CAR (lane 2) nor endogenous CAR (lane 4)
precipitated with anti-FLAG beads in the absence of NaV1.5 (lanes 6 and 9,
respectively). Eluates from HEK293 cells overexpressing both NaV1.5 and CAR
revealed that CAR coprecipitates with NaV1.5 (lane 8). e ¼ empty lane (lane 7).
Abbreviations as in Figure 2.
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557Mechanism(s) of ventricular conduction slowing and
arrhythmia vulnerability in CARD/L mice. Conduction
slowing in CARþ/ hearts may stem from altered car-
diomyocyte excitability (i.e., sodium channel function), cell-
to-cell coupling, tissue architecture, and combinations
thereof. We found no evidence for myocardial hypertrophy
or ﬁbrosis in CARþ/ hearts, making electrical remodeling
secondary to structural abnormalities unlikely. NaV1.5 pro-
tein levels were unchanged in CARþ/ hearts, but decreased
AP upstroke velocity was observed in CARþ/ myocytes.
Moreover, prolongation of electrocardiographic conduction
indexes after administration of ﬂecainide was more pro-
nounced in CARþ/ mice, further indicating the functional
relevance of the reduced sodium channel availability sec-
ondary to CAR haploinsufﬁciency. In cardiac-speciﬁc
inducible CAR knockout mice (i.e., post-natal CAR
knockout mice), Cx43 protein levels in ventricular myocar-
dium were reduced by approximately 40% (9). Although we
did not detect a signiﬁcant reduction of Cx43 expression in
CARþ/ hearts, this does not preclude the possibility that
subtle alterations in Cx43 expression and/or function may
be of relevance for conduction, especially during perturbed
conditions such as ischemia, as discussed in the following text.
Decreased membrane excitability and electrical uncou-
pling are key mechanisms for conduction slowing and con-
duction block during ischemia and provide a proarrhythmic
substrate for the development of re-entrant ventriculararrhythmias (20,21). The ventricular conduction slowing in
CARþ/ hearts likely exacerbates conduction slowing dur-
ing ischemia, thereby contributing to arrhythmogenesis in
this setting. The degree of conduction slowing observed
at baseline in CARþ/ hearts was modest and not sufﬁcient
to facilitate spontaneous or induced ventricular arrhyth-
mias. Thus, for (re-entrant) arrhythmias to occur, additional
electrical and/or structural perturbations appear to be
necessary, such as intercellular uncoupling or ischemia.
Infusion of carbenoxolone, a gap junctional uncoupler that
does not affect AP characteristics or underlying ion currents
(13), further decreased conduction velocity in both the
longitudinal and the transversal direction and increased
arrhythmia susceptibility in CARþ/ but not in WT hearts.
Of note, carbenoxolone also decreased conduction velocity
in WT hearts, and although the magnitude of the effects of
carbenoxolone was similar in both WT and CARþ/ hearts,
the absolute values of both CVL and CVT were lowest
in CARþ/ hearts after treatment with carbenoxolone. The
concomitant reduction in sodium channel availability in
CARþ/ hearts (but not in WT hearts) makes these hearts
more susceptible to arrhythmias in the presence of the un-
coupler carbenoxolone. Interestingly, an earlier onset of
ventricular arrhythmias during ex vivo regional ischemia
was also observed in hearts from Cx43 haploinsufﬁcient
mice (22), similar to our current observation in CARþ/
hearts. Because infusion of carbenoxolone is arrhythmogenic
in CARþ/ mice, subtle alterations in gap junction proteins
(undetected in our study) may contribute to the observed
ischemia-induced proarrhythmia in CARþ/ hearts. On the
other hand, arrhythmias in the early phase of ischemia are
predominantly associated with conduction delay (which can
facilitate re-entry) secondary to decreased membrane excit-
ability in depolarized tissue. Thus, reduced sodium channel
availability secondary to decreased INa (as shown in CAR
þ/
myocytes) may also contribute to increased arrhythmia
susceptibility.
Several animal models have been developed to study CAR.
Of these, the complete (germline) constitutive knockout
results in early embryonic lethality characterized by severe
cardiac morphological defects (23,24), cardiac-speciﬁc
knockout mice develop cardiomyopathy and/or atrioven-
tricular conduction disturbance (10), and the cardiac-speciﬁc
inducible knockout develops progressive atrioventricular
block (9). We chose to investigate the effects of CAR in
heterozygous knockout mice to assess the impact of a less
drastic reduction in CAR in the absence of remodeling,
which may better reﬂect the variability in CAR levels
occurring in human health and disease. Our observation that
CAR haploinsufﬁciency results in ventricular conduction
slowing appears to be in contrast to ﬁndings in cardiac-
speciﬁc knockout hearts, in which atrioventricular conduc-
tion was abnormal but ventricular conduction velocities
remained unaffected (10). However, this discrepancy may be
attributed to differences in measuring techniques, targeting
strategies, or genetic backgrounds (25).
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disk. CAR is a cell adhesion molecule with multiple
binding partners, including the scaffolding protein zonula
occludens 1, which in turn interacts with Cx43 (8,26).
Sodium channels interact with Cx43 and are regulated by
cell adhesion molecules, including the sodium channel
b-subunit and ankyrin-G (27,28). Thus, CAR may exert
its effects on sodium channel availability by both direct
and indirect mechanisms, which are likely not mutually
exclusive. Crucially, INa was reduced at the intercalated disk
of CARþ/ myocytes, whereas INa at the lateral myocyte
membrane was unaffected. Because sodium channels at the
intercalated disk are considered essential for proper con-
duction (15), a decrease in INa in this region is likely to
impair function. Indeed, our ﬁndings show that a relatively
modest reduction in INa at the intercalated disk is sufﬁcient
for sodium channel availability to be decreased. Moreover,
we found that CAR interacts with NaV1.5 in vitro, sug-
gesting that CAR affects sodium channel function through a
physical interaction with NaV1.5. The observation that
CAR affects INa speciﬁcally at the intercalated disk is in line
with the emerging concept that cross talk exists between
structural and electrical components in the intercalated disk
region (29–31).
Study limitations. Extrapolation from studies with animal
models to humans should be done with caution. We have
shown increased arrhythmia inducibility in CARþ/- hearts
after carbenoxolone and earlier onset of arrhythmia induc-
ibility in CARþ/- hearts after LAD ligation but did not
observe spontaneous arrhythmias in these settings.
Arrhythmia-inducing triggers in patients with ischemia-
induced arrhythmias may not be present in our model and
vice versa, and patients may differentially compensate CAR
deﬁciency.
Despite the observed CAR-dependent differences in AP
upstroke velocity and INa at the intercalated disk, we did not
detect changes in NaV1.5 protein. Nevertheless, small yet
functionally relevant differences in amount and/or localiza-
tion of NaV1.5 may be present, albeit below the detection
limit of our Western blot and immunohistochemistry assays.
Conclusions
Our expression studies in the human heart, combined with
electrophysiological studies in CARþ/ mice, establish a
novel role for CAR in mediating ventricular conduction and
arrhythmogenesis during conditions such as gap junctional
uncoupling or myocardial ischemia. CAR may have similar
modulatory effects on cardiac electrical activity in other
pathophysiological conditions, including dilated cardiomy-
opathy and myocarditis, which require further investigation.
The regulatory effects of CAR on sodium channel avail-
ability and cardiac conduction provide additional insight
into the complex mechanisms underlying arrhythmogenesis
during myocardial ischemia. Furthermore, genetic deter-
minants of arrhythmia susceptibility during myocardial ischemia(such as CAR) may constitute future targets for risk stratiﬁca-
tion and prevention of potentially lethal ventricular arrhythmias
in patients with coronary artery disease.Acknowledgments
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